Brief: Quidelortho Receives 510(K) Clearance For Savanna® Multiplex Molecular Platform And Savanna® Hsv 1+2/Vzv Pcr Assay
20/12/2023 21:43
Dec 20 (Reuters) - Quidelortho Corp QDEL.O :
* QUIDELORTHO RECEIVES 510(K) CLEARANCE FOR SAVANNA®
MULTIPLEX
MOLECULAR PLATFORM AND SAVANNA® HSV 1+2/VZV PCR ASSAY
* QUIDELORTHO CORP - SAVANNA WILL BE AVAILABLE TO
PROFESSIONAL
CUSTOMERS ON DECEMBER 20, 2023
Source text for Eikon: ID:nBw3vBjKMa
Further company coverage: QDEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quidelortho
See all newsBrief: Quidelortho Corp Enters Amendment No. 1 To Credit Agreement On Sept 23, 2026
QuidelOrtho Corp reports results for the quarter ended June 30 - Earnings Summary
Brief: QuidelOrtho Q2 EPS USD -1.36
Media: QuidelOrtho looks to sell testing unit as PE circles healthcare companies - FT
U.S. STOCKS ON THE MOVE-Bath & Body Works, Avis Budget, Cerebras